Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document lists various dermatology topics, treatments, and diagnostic methods.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

HIV can cause unusual and severe skin problems that are hard to treat.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.